Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease

- Nair, Prema M., Starkey, Malcolm R., Haw, Tatt Jhong, Liu, Gang, Collison, Adam M., Mattes, Joerg, Wark, Peter A., Morris, Jonathan C., Verrills, Nikki M., Clark, Andrew R., Ammit, Alaina J., Hansbro, Philip M.

Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression

- Ross, E. A., Naylor, A. J., Dominguez, S., Perlman, H., Verrills, N. M., Kollias, G., Vitek, M. P., Filer, A., Buckley, C. D., Dean, J. L., Clark, A. R., O'Neil, J. D., Crowley, T., Ridley, M. L., Crowe, J., Smallie, T., Tang, T. J., Turner, J. D., Norling, L. V.

Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Activiating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hasbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Immunoregulatory therapies for inflammatory diseases

- Monogar, Prema Mono Nair